PROCEPT BioRobotics Corp. Files Q3 2024 10-Q
Ticker: PRCT · Form: 10-Q · Filed: Oct 28, 2024 · CIK: 1588978
Sentiment: neutral
Topics: 10-Q, financials, medical-devices
TL;DR
PROCEPT BioRobotics filed its Q3 2024 10-Q. Check financials.
AI Summary
PROCEPT BioRobotics Corp. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the year. Key financial data and operational details for this period are presented.
Why It Matters
This filing provides investors and analysts with the latest financial performance and operational updates for PROCEPT BioRobotics Corp., crucial for understanding the company's trajectory in the medical device sector.
Risk Assessment
Risk Level: medium — The company operates in the medical device industry, which is subject to regulatory, competitive, and technological risks.
Key Players & Entities
- PROCEPT BioRobotics Corp (company) — Filer of the 10-Q
- 20240930 (date) — End of the reporting period
- 20241028 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter and nine months ended September 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on October 28, 2024.
What is the company's Standard Industrial Classification (SIC) code?
The company's SIC code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
What is the company's state of incorporation?
PROCEPT BioRobotics Corp. is incorporated in Delaware (DE).
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
Filing Stats: 4,672 words · 19 min read · ~16 pages · Grade level 15.4 · Accepted 2024-10-28 16:00:44
Key Financial Figures
- $0.00001 — ange on which registered Common stock, $0.00001 par value per share PRCT Nasdaq Global
Filing Documents
- prct-20240930.htm (10-Q) — 922KB
- a101amendedandrestated20.htm (EX-10.1) — 58KB
- prct-ex311soxcertification.htm (EX-31.1) — 10KB
- prct-ex312soxcertification.htm (EX-31.2) — 10KB
- prct-ex321soxcertification.htm (EX-32.1) — 6KB
- prct-ex322soxcertification.htm (EX-32.2) — 6KB
- a101amendedandrestated20001.jpg (GRAPHIC) — 224KB
- a101amendedandrestated20002.jpg (GRAPHIC) — 269KB
- a101amendedandrestated20003.jpg (GRAPHIC) — 269KB
- a101amendedandrestated20004.jpg (GRAPHIC) — 263KB
- a101amendedandrestated20005.jpg (GRAPHIC) — 232KB
- a101amendedandrestated20006.jpg (GRAPHIC) — 262KB
- a101amendedandrestated20007.jpg (GRAPHIC) — 234KB
- a101amendedandrestated20008.jpg (GRAPHIC) — 268KB
- a101amendedandrestated20009.jpg (GRAPHIC) — 278KB
- a101amendedandrestated20010.jpg (GRAPHIC) — 244KB
- a101amendedandrestated20011.jpg (GRAPHIC) — 274KB
- a101amendedandrestated20012.jpg (GRAPHIC) — 270KB
- a101amendedandrestated20013.jpg (GRAPHIC) — 244KB
- a101amendedandrestated20014.jpg (GRAPHIC) — 218KB
- a101amendedandrestated20015.jpg (GRAPHIC) — 234KB
- a101amendedandrestated20016.jpg (GRAPHIC) — 261KB
- a101amendedandrestated20017.jpg (GRAPHIC) — 74KB
- 0001588978-24-000030.txt ( ) — 11360KB
- prct-20240930.xsd (EX-101.SCH) — 35KB
- prct-20240930_cal.xml (EX-101.CAL) — 60KB
- prct-20240930_def.xml (EX-101.DEF) — 151KB
- prct-20240930_lab.xml (EX-101.LAB) — 532KB
- prct-20240930_pre.xml (EX-101.PRE) — 358KB
- prct-20240930_htm.xml (XML) — 810KB
Financial Information
Part I. Financial Information Item 1. Condensed Consolidated Financial Statements (unaudited) 4 Condensed Consolidated Balance Sheets 4 Condensed Consolidated Statements of Operations and Comprehensive Loss 5 Condensed Consolidated Statements of Stockholders' Equity 6 Condensed Consolidated Statements of Cash Flows 8 Notes to Condensed Consolidated Financial Statements 9 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 17 Item 3. Quantitative and Qualitative Disclosure About Market Risk 28 Item 4.
Controls and Procedures
Controls and Procedures 28
Other Information
Part II. Other Information Item 1.
Legal Proceedings
Legal Proceedings 30 Item 1A.
Risk Factors
Risk Factors 30 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 31 Item 3. Defaults Upon Senior Securities 31 Item 4. Mine Safety Disclosures 31 Item 5. Other Information 31 Item 6. Exhibits 32
Signatures
Signatures __________________ 2 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains forward-looking statements. All statements other than statements of historical facts contained in this Quarterly Report are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as "may," "can", "will," "would," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential," or "continue" or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. All statements other than statements of historical facts contained in this Quarterly Report, including without limitation statements regarding our business model and strategic plans for our products, technologies and business, including our implementation thereof, the timing of and our ability to obtain and maintain regulatory approvals, our commercialization, marketing and manufacturing capabilities and strategy, our expectations about the commercial success and market acceptance of our products, the sufficiency of our cash, cash equivalents and short-term investments, and the plans and objectives of management for future operations and capital expenditures are forward-looking statements. The forward-looking statements in this Quarterly Report are only predictions and are based largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements speak only as of the date of this Quarterly Report and are subject to a number of known and unknown risks, uncertainties, and assumptions, including those described under the sections in this Quarterly Report entitled "Risk Factors" and "